<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
CUBIST PHARMACEUTICALS, INC.
--------------------------------------------------------
(Name of Issuer)
COMMON STOCK $.001 PAR VALUE
--------------------------------------------------------
(Title of Class of Securities)
229 678 610
--------------------------------------------------------
(CUSIP Number)
GINETTE DEPELTEAU
SOFINOV,
SOCIETE FINANCIERE D'INNOVATION, INC.
1981 MCGILL COLLEGE AVENUE
MONTREAL, QUEBEC HCA 3C7
(514) 847-5901
--------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
[FEBRUARY 24, 2000]
--------------------------------------------------------
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rules 13d-1(e), 13d-1(f) or 13d-1(g), check
the following box / /.
Note: Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7 for other
parties to whom copies are to be sent.
(Continued on following pages)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosure provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
1
<PAGE>
CUSIP No. 229 678 610
- -------------------------------------------------------------------------------
(1) Name of Reporting Person. S.S. or I.R.S. Identification No. of Above
Person
SOFINOV, SOCIETE FINANCIERE D'INNOVATION, INC.
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group (b) / /
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Source of Funds*
WC
- -------------------------------------------------------------------------------
(5) Check Box if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e) / /
- -------------------------------------------------------------------------------
(6) Citizenship or Place of Organization
MONTREAL, QUEBEC, CANADA
- -------------------------------------------------------------------------------
Number of Shares (7) Sole Voting
Beneficially Owned Power 2,140,935(1)
by Each Reporting --------------------------------------------------
Person With (8) Shared Voting
Power --
--------------------------------------------------
(9) Sole Dispositive
Power 2,140,935
--------------------------------------------------
(10) Shared Dispositive
Power --
- -------------------------------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
2,140,935
- -------------------------------------------------------------------------------
(12) Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares
/ /
- -------------------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11)
8.01%
- -------------------------------------------------------------------------------
(14) Type of Reporting Person
CO
- -------------------------------------------------------------------------------
(1) Includes 1,111,112 shares of Common Stock of the Company issuable
upon exercise of a warrant. See Item 4 below.
*SEE INSTRUCTION BEFORE FILLING OUT!
2
<PAGE>
CUSIP No. 229 678 610
- -------------------------------------------------------------------------------
(1) Name of Reporting Person. S.S. or I.R.S. Identification No. of Above
Person
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC.
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group (b) / /
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Source of Funds*
WC
- -------------------------------------------------------------------------------
(5) Check Box if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e) / /
- -------------------------------------------------------------------------------
(6) Citizenship or Place of Organization
MONTREAL, QUEBEC, CANADA
- -------------------------------------------------------------------------------
Number of Shares (7) Sole Voting
Beneficially Owned Power 2,140,935(1)
by Each Reporting --------------------------------------------------
Person With (8) Shared Voting
Power --
--------------------------------------------------
(9) Sole Dispositive
Power 2,140,935
--------------------------------------------------
(10) Shared Dispositive
Power --
- -------------------------------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
2,140,935
- -------------------------------------------------------------------------------
(12) Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares
/ /
- -------------------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11)
8.01%
- -------------------------------------------------------------------------------
(14) Type of Reporting Person
CO
- -------------------------------------------------------------------------------
(1) Includes 1,111,112 shares of Common Stock of the Company issuable
upon exercise of a warrant. See Item 4 below.
*SEE INSTRUCTION BEFORE FILLING OUT!
3
<PAGE>
This Amendment No. 4, dated February 24, 2000 is being filed jointly on
behalf of Caisse de depot et placement du Quebec ("CDPQ") and by its
wholly-owned subsidiary, SOFINOV, Societe financiere d'innovation, inc.
("Sofinov") pursuant to Rule 13d-2(a) under the Securities Exchange Act of
1934, as amended (the "Exchange Act") pursuant to a Joint Filing Agreement
dated February 24, 2000, between CDPQ and Sofinov, a copy of which is
attached hereto as Exhibit 1.
ITEM 1. SECURITY AND ISSUER.
This Schedule 13D relates to the Common Stock, par value $.001 per
share ("Common Stock"), of Cubist Pharmaceuticals, Inc., a Delaware
corporation (the "Company"). The address of the principal executive
offices of the Company is 24 Emily Street, Cambridge, Massachusetts
02139.
ITEM 2. IDENTITY AND BACKGROUND
This Schedule 13D is filed jointly on behalf of CDPQ, a corporation
without share capital and an agent of the Crown in right of the
Province de Quebec, created by a special act of the Legislature of
the Province de Quebec, and Sofinov, a legal entity duly
incorporated under part 1A of the Companies ACT (Quebec) and a
wholly-owned subsidiary of CDPQ, pursuant to Rule 13d-1(f)(1) under
the Exchange Act.
The principal business address and the principal office address of
each of CDPQ and Sofinov is 1981, Avenue McGill College, Suite
1330, Montreal, Quebec, H3A 3C7, Canada. The name, business
address, citizenship and present principal occupation of each
director and executive officer of CDPQ and Sofinov are set forth on
Schedule I.
To the best knowledge of CDPQ and Sofinov, none of the persons
listed on Schedule I has, during the last five years, (i) been
convicted in a criminal proceeding (excluding traffic violations or
similar misdemeanors) or (ii) been a party to a civil proceeding of
a judicial or administrative body of competent jurisdiction and as
a result of such proceeding was or is subject to a judgment, decree
or final order enjoining future violations of, or prohibiting or
mandating activities subject to, United States federal or state
securities laws or finding any violation with respect to such laws.
4
<PAGE>
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
All the funds required to purchase the Initial Shares (as defined
below) were obtained from the working capital of Sofinov.
ITEM 4. PURPOSE OF TRANSACTION
Pursuant to a Purchase Agreement (the "Purchase Agreement") dated
September 10, 1998, Sofinov acquired beneficial ownership of
3,497,335 shares of Common Stock in a private placement through (i)
the purchase of 2,386,223 shares of Common Stock (the "Initial
Shares") and (ii) the granting by the Company to Sofinov of a
warrant (the "Warrant") exercisable in whole or in part into
1,111,112 shares of Common Stock (the "Warrant Shares") with an
expiration date of September 23, 2003.
Pursuant to the exercise of certain registration rights granted to
Sofinov in connection with the private placement, the Initial
Shares and the Warrant Shares were registered for resale by Sofinov
on a Registration Statement on Form S-3 which was filed with the
SEC on September 30, 1998.
Sofinov sold 456,400 Initial Shares for US$28,835,191 as set forth
on Exhibit 2.
Pursuant to the Purchase Agreement, Sofinov has the right to
designate one person to be elected to the board of directors of the
Company. The Company has agreed to take all steps necessary and
appropriate and otherwise use its best efforts to cause the
individual designated by Sofinov to be duly and properly elected to
the board of directors of the Company. This right will terminate
when Sofinov ceases to own at least thirty-three and one-third
percent (33 1/3%) of the Initial Shares purchased by it under the
Purchase Agreement.
Except as specifically set forth in this Item 4, neither CDPQ nor
Sofinov has any plans or proposals which relate to or would result
in any of the actions or effects set forth in items (a) through (e)
of Item 5 of Schedule 13D, although either of them may develop such
plans or proposals.
CDPQ and Sofinov intend to review on a continuing basis their
investment in the Company. As of the date of this Schedule 13D, no
determination has been made by CDPQ or Sofinov to acquire
additional shares of Common Stock or dispose of any shares of
Common Stock now held by them, although either of them may decide
5
<PAGE>
to so acquire or dispose of shares of Common Stock. Any such
determination will depend on market conditions prevailing from time
to time and on other conditions which may be applicable depending
on the nature of the transaction or transactions involved.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) With recent transactions, Sofinov is the direct beneficial owner of
2,140,935 shares of Common Stock (including the Warrant Shares)(the
"Sofinov Shares"). CDPQ may be deemed to be the indirect,
beneficial owner of the Sofinov Shares. The Sofinov Shares
represent approximately 8.01% of the 25,605,455 shares of Common
Stock of the Company outstanding on the date hereof, based upon
information provided by the company, plus the Warrant Shares.
(b) CDPQ has the power to vote and dispose of the Sofinov Shares.
(c) Except as set forth in this Schedule 13D, none of CDPQ, Sofinov or,
to the best knowledge of CDPQ or Sofinov, any person named on
Schedule I hereto, owns any shares of the Company's Common Stock,
and none has purchased or sold any shares of the Company's Common
Stock during the past 60 days.
(d) Except as set forth in this Schedule 13D, no person is known by
CDPQ or Sofinov to have the right to receive or the power to direct
the receipt of dividends from, or the proceeds from the sale of,
the shares of Common Stock of the Company beneficially owned by
CDPQ and Sofinov.
(e) Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
RESPECT TO SECURITIES OF THE ISSUER
Except as set forth in this Schedule 13D, there are no contracts,
arrangements, understandings or relationships (legal or otherwise)
among the persons referred to in Item 2 of this Schedule 13D or
between such persons and any other person with respect to any of
the securities of the Company, including, but not limited to, any
relating to the transfer or voting of any of such securities,
finder's fees, joint ventures, loan or option arrangements, puts or
calls, guarantees of profits, division of profits or loss or the
giving or withholding of proxies.
ITEM 7. MATERIALS TO BE FILED AS EXHIBITS
6
<PAGE>
1. Joint Filing Agreement dated February 24, 2000 by and between
Sofinov and CDPQ.
2. Joint Filing Table of Dates, Number of Shares sold and price
per Share of Sales.
SIGNATURES
After reasonable inquiry and to the best knowledge and belief of the
undersigned, the undersigned certifies that the information set forth in this
statement is true, complete and correct.
Date: February 24, 2000
SOFINOV, SOCIETE FINANCIERE D'INNOVATION, INC.
By: __________________________________________
Name: Ginette Depelteau
Title: Corporate Secretary
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC.
By: __________________________________________
Name: Ginette Depelteau
Title: General Secretary - Director
7
<PAGE>
SCHEDULE I
LIST OF EXECUTIVE OFFICERS AND DIRECTORS OF SOFINOV
<TABLE>
<CAPTION>
PRINCIPAL
DIRECTORS BUSINESS ADDRESS OCCUPATION
<S> <C> <C>
Jean-Claude Scraire Caisse de depot et placement du Quebec Chairman
1981, Avenue McGill College
Montreal (Quebec) H3A 3C7
Line Boisvert Caisse de depot et placement du Quebec Director and
1981, Avenue McGill College Portfolio
Montreal (Quebec) H3A 3C7 Manager
Jacques M. Brault Levesque Beaubien Geoffrion Inc. Senior
1155, Metcalfe, 5e etage Vice-President
Montreal, (Quebec) H3B 4S9
Denis Dionne SOFINOV, Societe financiere d'innovation, inc. President
1981, Avenue McGill College
Montreal (Quebec) H3A 3C7
Claude Lajeunesse Ryerson Polytechnic University President and
350, Victoria Street Vice Chancellor
Toronto (Ontario) H2M 2V1
Serge Martin Martin International President
500, Place d'Armes, Suite 2910
Montreal, (Quebec) H2Y 2W2
Guy Morneau Regie des rentes du Quebec Chairman of the
2600 boul. Laurier, bureau 546 Board and
Quebec (Quebec) G1V 4T3 President
Normand Provost Caisse de depot et placement du Quebec Vice-President
1981, Avenue McGill College Coordinator
Montreal (Quebec) H3A 3C7
</TABLE>
8
<PAGE>
SCHEDULE 1
LIST OF EXECUTIVE OFFICERS AND DIRECTORS OF SOFINOV
<TABLE>
<CAPTION>
PRINCIPAL
OFFICERS BUSINESS ADDRESS OCCUPATION
<S> <C> <C>
Jean-Claude Scraire Caisse de depot et placement du Quebec Chairman
1981, Avenue McGill College
Montreal (Quebec) H3A 3C7
Denis Dionne SOFINOV, Societe financiere d'innovation, inc. President
1981, Avenue McGill College
Montreal (Quebec) H3A 3C7
Pierre Pharand SOFINOV, Societe financiere d'innovation, inc. Vice-President
1981, Avenue McGill College
Montreal (Quebec) H3A 3C7
Bertrand Lauzon Caisse de depot et placement du Quebec Vice-President,
1981, Avenue McGill College Finance and Control
Montreal (Quebec) H3A 3C7
Ginette Depelteau Caisse de depot et placement du Quebec Secretary
1981, Avenue McGill College
Montreal (Quebec) H3A 3C7
</TABLE>
9
<PAGE>
SCHEDULE 1
LIST OF EXECUTIVE OFFICERS AND DIRECTORS OF CDPQ
<TABLE>
<CAPTION>
DIRECTORS BUSINESS ADDRESS PRINCIPAL OCCUPATION
<S> <C> <C>
Jean-Claude Scraire Caisse de depot et placement du Quebec Chairman
1981, avenue McGill College
Montreal (Quebec) H3A 3C7
Guy Morneau Regie des rentes du Quebec Chairman of the
2600, boul. Laurier, bureau 546 Board and President
Quebec (Quebec) G1V 4T3
Jean-Claude Bachand Byers Casgrain Lawyer
1, Place Ville-Marie
Bureau 3900
Montreal (Quebec) H3B 4M7
Claude Beland La Confederation des Caisses populaires President
et d'economie Desjardins du Quebec
100, avenue des Commandeurs
Levis (Quebec) G6V 7N5
Luc Bessette Commission administrative des regimes President
de retraite et d'assurances
475, rue Saint-Amable
Quebec (Quebec) G1R 5X3
Rodrigue Biron Rodrigue Biron & Associes
305, chemin de la Place St-Laurent
St-Augustin-de-Desmaures
Cap-Rouge (Quebec) G1Y 3G9
Yves Filion Hydro-Quebec Deputy Chief
75, boul. Rene-Levesque Ouest Executive Officer
Montreal (Quebec) and Chief
H2Z 1A4 Financial Officer
Jean-Yves Gagnon Societe de l'assurance automobile General Manager
du Quebec
333, boul. Jean-Lesage
Quebec (Quebec) G1K 8J6
Henri Masse Federation des travailleurs et President
travailleuses du Quebec
545, boul. Cremazie Est, 17e etage
Montreal, (Quebec) H2M 2V1
</TABLE>
10
<PAGE>
SCHEDULE 1
LIST OF EXECUTIVE OFFICERS AND DIRECTORS OF CDPQ
<TABLE>
<CAPTION>
DIRECTORS BUSINESS ADDRESS PRINCIPAL OCCUPATION
<S> <C> <C>
Gilles Godbout Ministere des Finances Deputy Minister
12, rue St-Louis
Quebec (Quebec) G1R 5L3
Thomas O. Hecht Technologies IBEX Inc. Chairman Emeritus
5485, rue Pare
Montreal (Quebec) H4P 1P7
Marc Laviolette Confederation des syndicats nationaux President
1601, rue Delorimier
Montreal (Quebec) H2K 4M5
Nicole Trudeau Commission municipale du Quebec Vice-President
2, Complexe Desjardins
Suite 3100, East Tower
Montreal (Quebec) H5B 1B2
</TABLE>
11
<PAGE>
SCHEDULE 1
LIST OF EXECUTIVE OFFICERS AND DIRECTORS OF CDPQ
<TABLE>
<CAPTION>
OFFICERS BUSINESS ADDRESS PRINCIPAL OCCUPATION
<S> <C> <C>
Jean-Claude Scraire Caisse de depot et placement du Quebec Chairman
1981, avenue McGill College
Montreal (Quebec) H3A 3C7
Fernand Perreault Same Senior Vice-president
Caisse Real Estate
Group and Mortgage
Investments
Michel Nadeau Same Senior Vice-president
Investment Planning and
Strategic Affairs
Ginette Depelteau Same General Secretary -
Director
</TABLE>
12
<PAGE>
EXHIBIT INDEX
<TABLE>
<CAPTION>
EXHIBIT
- -------
<S> <C>
1. Joint Filing Agreement dated February 24, 2000 by and between Sofinov
and CDPQ.
2. Joint Filing Table of Dates, Number of Shares sold and price per Share of
Sales.
</TABLE>
13
<PAGE>
EXHIBIT 1
AGREEMENT
The undersigned hereby agree that this statement on Schedule 13D with
respect to beneficial ownership of shares of common stock of Cubist
Pharmaceuticals, Inc. is filed jointly, on behalf of each of them.
Dated: February 24, 2000
SOFINOV, SOCIETE FINANCIERE D'INNOVATION, INC.
By: __________________________________________
Name: Denis Dionne
Title: President
By: __________________________________________
Name: Ginette Depelteau
Title: Corporate Secretary
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC.
By: __________________________________________
Name: Michel Nadeau
Title: Senior Vice-president
Investment Planning and
Strategic Affairs
By: __________________________________________
Name: Ginette Depelteau
Title: General Secretary - Director
14
<PAGE>
EXHIBIT 2
- ------------------------------------------------------------------------------
TABLE OF SALES OF
CUBIST PHARMACEUTICALS, INC.
- ------------------------------------------------------------------------------
SALES
- ------------------------------------------------------------------------------
<TABLE>
<CAPTION>
PRICE PER SHARE
DATE NUMBER OF SHARES IN US DOLLARS
- ---- ---------------- ---------------
<S> <C> <C>
February
22 176,200 42.60
23 61,400 41.47
24 218,800 44.32
</TABLE>
15
